Chronic stress disrupts the connection between your gut and brain, known as the gut-brain axis. This two-way system influences your mental health, but stress can harm your gut microbiome, weaken your gut lining, and trigger brain inflammation. These changes are linked to anxiety and depression.
Key takeaways:
- Stress activates the HPA axis, releasing cortisol, which damages the gut barrier and alters gut bacteria.
- A "leaky gut" allows harmful substances into the bloodstream, leading to systemic inflammation and neuroinflammation.
- Brain inflammation alters neurotransmitters like serotonin, worsening mood disorders.
- Gut health interventions, such as probiotics, anti-inflammatory diets, and stress management, show promise in improving mental health.
Emerging research highlights how addressing gut health could complement mental health treatments. Products like Begin Rebirth RE-1™, combining probiotics and prebiotics, aim to restore gut balance and reduce inflammation, though further studies are needed to refine these approaches.
How to Fix Your Brain-Gut Connection: Anxiety and the Brain-Gut Microbiome Axis
How Stress Hormones Disrupt the Gut-Brain Axis
When life gets stressful, your body kicks into high gear with a hormonal response designed to help you tackle immediate challenges. But when stress becomes a constant companion, it can throw off the delicate balance between your gut and brain, potentially leading to mental health struggles.
The HPA Axis and Stress Response
At the heart of your stress response lies the hypothalamic-pituitary-adrenal (HPA) axis, a system that orchestrates your body's reaction to stress. When your brain senses danger or a challenge, the hypothalamus releases corticotropin-releasing hormone (CRH), which signals the pituitary gland to produce adrenocorticotropic hormone (ACTH). ACTH then prompts your adrenal glands to release cortisol, the main stress hormone in humans [3][4].
In short bursts, cortisol is your ally. It helps you stay focused, mobilizes energy, and temporarily adjusts your immune response. This acute stress response is like an on-off switch - once the stressor is gone, your body returns to normal [3][4].
But things go awry with chronic stress. Whether it's a demanding job, financial worries, or the ongoing challenges of caregiving, prolonged stress keeps the HPA axis in overdrive. This leads to HPA hyperactivity, where cortisol levels remain elevated and the usual checks and balances in the system fail. This pattern is often seen in people dealing with depression or anxiety [4].
Chronic cortisol exposure doesn’t just affect your mood - it wreaks havoc on your gut. Stress hormones influence the gut through the autonomic and enteric nervous systems, disrupting normal functions like digestion and mucus production, increasing gut sensitivity, and weakening the protective gut lining [3][4]. CRH receptors on gut cells and immune cells trigger the release of inflammatory molecules, further damaging the gut barrier [3].
In the long run, this persistent HPA activation not only throws off hormonal balance but also weakens the gut's defenses.
Gut Barrier Damage and Microbiota Changes
Your gut lining acts like a bouncer at a club, letting in nutrients while keeping harmful substances out. This selective barrier relies on tight junction proteins - like occludin, claudins, and zonula occludens-1 - to seal the spaces between cells. Chronic stress and high cortisol levels can disrupt these proteins, leading to increased intestinal permeability, often called "leaky gut" [3][4][9].
When the gut barrier falters, harmful substances like lipopolysaccharide (LPS) - a component of certain bacteria - can leak into the bloodstream. This process is a hallmark of stress-related gut barrier damage, as confirmed by clinical markers [2][4].
Stress doesn’t stop at damaging the barrier - it also shifts the balance of gut bacteria. Chronic stress tends to reduce beneficial microbes like Lactobacillus and Bifidobacterium, while encouraging the growth of harmful, inflammation-promoting bacteria [3][9]. This matters because good bacteria produce short-chain fatty acids (SCFAs) like butyrate, which help maintain the gut lining and send anti-inflammatory signals. Losing these helpful microbes can create a vicious cycle of worsening gut permeability and immune activation [3].
Stress-induced gut inflammation can even affect the brain. Long-term inflammation disrupts the gut microbiome and activates microglia, the brain’s immune cells, which can lead to neurotoxicity and, in some cases, brain damage, as shown in experimental studies [3].
The Cycle Between Stress and Microbiota
This gut damage and microbial imbalance create a feedback loop, where changes in the microbiota amplify stress responses.
The relationship between stress and gut bacteria works both ways. Stress affects your microbiome, and in turn, your microbiome influences how your body handles stress. For example, germ-free mice - those raised without gut bacteria - show exaggerated HPA responses to mild stress, with elevated ACTH and corticosterone levels. Introducing specific bacteria like Bifidobacterium infantis can normalize these heightened responses [3][6].
"Certain probiotics can encourage GABA, a calming brain messenger, and may lower cortisol, the stress hormone. Researchers testing Lactobacillus helveticus and Bifidobacterium longum strains found that people reported lower anxiety and reduced cortisol after one month. These calming signals can travel along the vagus nerve, the parasympathetic nerve responsible for 'rest' signals between the gut and brain." - Verified clinician, Internal Medicine [1]
Here’s how the cycle unfolds: stress activates the HPA axis, raising cortisol levels. This disrupts the gut barrier and fosters dysbiosis - an imbalance in gut bacteria. The weakened barrier allows harmful bacterial products to enter the bloodstream, triggering immune activation and inflammation. These inflammatory signals, along with altered vagus nerve activity, further stimulate the HPA axis, leading to more cortisol release, additional gut damage, and worsening dysbiosis. It’s a self-perpetuating cycle [3][4].
Stress-driven microbiota changes also influence the brain by affecting neurotransmitters like serotonin, altering vagal nerve signals, and activating immune pathways that contribute to anxiety and depression-like symptoms [3][4][9].
Research from both animal and human studies highlights this two-way relationship as a key factor in gut-brain axis issues. For many Americans dealing with chronic stressors like work demands, financial pressures, or caregiving responsibilities, this stress-microbiota cycle plays a significant role in mental health challenges.
Breaking this cycle involves managing stress to calm the HPA axis while strengthening the gut barrier and restoring microbial balance. This dual approach is the foundation for emerging therapies aimed at improving gut-brain health.
How Gut Inflammation Leads to Brain Inflammation
When the gut barrier is compromised, harmful bacterial products can enter the bloodstream, triggering an immune response that extends to the brain. This connection sheds light on why digestive issues often coincide with mental health challenges.
Immune Activation and Inflammatory Cytokines
When the gut lining becomes permeable, bacterial molecules like lipopolysaccharide (LPS) - a component of certain bacterial membranes - leak into the bloodstream. LPS acts as a distress signal, activating immune cells through Toll-like receptor 4 (TLR4) and the NLRP3 inflammasome [3][5].
In response, immune cells such as monocytes, macrophages, and dendritic cells release pro-inflammatory cytokines like interleukin-1 beta (IL-1β), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-α) [3][5]. While these cytokines are crucial for fighting infections, their prolonged presence can lead to systemic inflammation.
Research shows that individuals with major depressive disorder often have elevated levels of these cytokines, with higher levels linked to more severe symptoms and resistance to treatment [4]. Additionally, people with depression frequently exhibit higher levels of antibodies (IgA and IgM) against LPS from gut bacteria, suggesting increased exposure to bacterial products due to a weakened intestinal barrier [4].
These cytokines communicate with the brain in several ways: traveling through the bloodstream, activating the vagus nerve (which connects the gut and brain), or being carried into the central nervous system by immune cells [3][4]. Once in the brain, they target the blood-brain barrier, compromising its integrity.
Effects on the Blood-Brain Barrier and Microglia
The blood-brain barrier (BBB) acts as a selective filter, protecting the brain by allowing nutrients in while keeping harmful substances out. However, inflammatory cytokines like TNF-α and IL-1β can weaken this barrier. They reduce the expression of tight junction proteins and increase molecules like ICAM-1 and VCAM-1, making the BBB more permeable and allowing immune cells and bacterial products to enter brain tissue [3][5].
Chronic gut inflammation can simultaneously disrupt both the intestinal barrier and the BBB, creating what’s often referred to as a "leaky BBB" [3]. Once the BBB is compromised, inflammatory mediators and immune cells infiltrate the brain, activating microglia, the brain's resident immune cells. Activated microglia adopt a pro-inflammatory state, which can harm neuronal connections [3][10].
In studies of chronic intestinal inflammation, researchers have observed persistent microglial activation, infiltration of immune cells into brain tissue, and even neuronal damage [3]. Imaging studies also show that during systemic inflammation, microglia initially try to protect the BBB but eventually contribute to its breakdown, perpetuating a cycle of neuroinflammation [3].
This prolonged microglial activation damages synapses, disrupts neurogenesis (the birth of new neurons), and impairs neural networks. These changes have been linked to depressive symptoms, cognitive decline, and increased susceptibility to neurodegenerative diseases [3][4][10]. Inflammation also disrupts neurotransmitter balance, further affecting brain function.
Tryptophan Metabolism and Neurotransmitter Changes
Inflammation alters how the body processes tryptophan, a precursor to serotonin. Instead of being converted into serotonin, tryptophan is redirected into the kynurenine pathway through the activation of enzymes like IDO and TDO [4][5].
This shift reduces serotonin production, contributing to symptoms like low mood, anhedonia (loss of pleasure), and sleep disturbances often seen in depression [4]. Studies have shown that inflammatory triggers, such as immune therapies or experimental LPS exposure, increase the kynurenine-to-tryptophan ratio, correlating with depressive symptoms [4][5].
The kynurenine pathway produces metabolites that can be either harmful or protective. Inflammatory conditions favor the production of quinolinic acid, a neurotoxic compound that overstimulates neurons through NMDA receptors, leading to oxidative stress and neuronal damage [4]. At the same time, levels of kynurenic acid, a protective metabolite, often decrease [4].
This imbalance has been observed in patients with major depressive disorder, with higher levels of quinolinic acid linked to more severe symptoms, cognitive deficits, and even suicidality [4][5]. Animal studies also show that gut inflammation increases intestinal permeability, circulating LPS, and IDO activity, leading to depressive-like behaviors. Blocking IDO activity often reduces these effects [3][4][5].
Human studies further confirm this connection. People with inflammatory conditions, such as inflammatory bowel disease or chronic viral infections, frequently show elevated kynurenine pathway metabolites and face a higher risk of depression and anxiety [4]. Treatments like interferon-alpha therapy, which strongly activate IDO, are known to induce depressive symptoms in many patients, with severity directly tied to kynurenine pathway activation [4][5].
The interplay between gut inflammation, immune activation, and tryptophan metabolism creates a powerful link between gut health and brain health. This cascade of events - from a leaky gut to systemic inflammation, BBB disruption, and altered neurotransmitter pathways - helps explain why chronic gut issues often go hand in hand with mental health struggles.
sbb-itb-1bbfe7f
Evidence Linking Gut-Brain Dysfunction to Anxiety and Depression
Over the years, research has increasingly pointed to a connection between gut health and mood disorders. Studies in both animals and humans have consistently shown that gut dysfunction plays a role in conditions like anxiety and depression. Let’s explore what the evidence tells us.
What Animal Studies Reveal
Animal research offers some of the clearest insights into how gut health influences mental health. For example, chronic stress in animals has been shown to disrupt gut bacteria, weaken the intestinal barrier, and trigger an inflammatory response. These changes often correlate with behaviors associated with anxiety and depression, such as losing interest in enjoyable activities or exhibiting avoidance behaviors [3][4].
Stress also appears to impair the tight junction proteins that maintain the integrity of both the intestinal and blood-brain barriers. This opens pathways for inflammation in the gut to affect the brain directly, leading to neuroinflammation and subsequent behavioral changes [3].
Experiments manipulating gut bacteria further highlight their importance. Germ-free mice, which lack gut microbes, show heightened stress responses and elevated stress hormones. However, introducing beneficial bacteria like Bifidobacterium infantis early in their development can normalize these responses. This suggests a critical window during which gut microbes shape brain function [9].
Fecal microbiota transplantation (FMT) studies add more evidence. When gut bacteria from stressed or depressed animals are transferred to microbiota-depleted recipients, the recipients develop anxiety-like behaviors, altered stress responses, and signs of neuroinflammation [3]. Conversely, introducing specific probiotics or healthy microbiota can reduce inflammation in the brain and improve behavior [3][4].
One standout study in 2019 focused on the probiotic Lactobacillus helveticus BR-MCC1848. This strain was shown to counteract the effects of chronic stress in mice, particularly by reversing changes in genes linked to nervous system development and stress signaling. Researchers concluded that it might serve as a preventive tool for stress-induced depression [1].
"Probiotics can benefit the central nervous system via the microbiota-gut-brain axis, which raises the possibility that probiotics are effective in managing depression. MCC1848 ameliorated sCSDS-induced gene expression alterations in signal transduction or nervous system development. These findings suggest that MCC1848 supplementation is useful as a preventive strategy for chronic-stress-induced depression." [1]
These findings from animal studies highlight how gut bacteria influence stress responses, emotional regulation, and behavior, paving the way for similar observations in humans.
Human Studies on Gut-Brain Dysregulation
Human research mirrors many of the findings seen in animals, especially in individuals with major depressive disorder (MDD) and anxiety disorders. Several key patterns have emerged from these studies.
For instance, people with depression often show signs of a compromised intestinal barrier. Markers like elevated lipopolysaccharides (LPS) and zonulin, alongside heightened antibodies to bacterial products, suggest that harmful substances are leaking through the gut lining and triggering chronic inflammation [4].
Microbiome profiling has revealed that individuals with depression tend to have reduced bacterial diversity and imbalances in key bacterial groups, such as Firmicutes and Bacteroidetes. Beneficial bacteria, like Faecalibacterium and Bifidobacterium, which produce short-chain fatty acids crucial for gut and brain health, are often depleted. These alterations often correlate with symptom severity, elevated cortisol levels, and markers of neuroinflammation [2][4][9].
Inflammation appears to play a central role. People with depression frequently show higher levels of inflammatory markers like IL-6, TNF-α, and C-reactive protein (CRP). These markers are often linked to more severe symptoms and resistance to treatment [4]. Neuroimaging studies also reveal signs of inflammation in the brain, such as microglial activation [4].
Additionally, many individuals with depression exhibit hyperactivity in the hypothalamic-pituitary-adrenal (HPA) axis, a stress-response system closely tied to gut inflammation [4]. Reviews of these findings suggest that stress-induced gut dysfunction contributes to systemic inflammation, which disrupts neurotransmitter production and metabolism - key factors in anxiety and depression [2][3][4].
Interventions targeting the gut have shown promise. Randomized controlled trials of probiotics, often referred to as psychobiotics, have reported improvements in mood and reductions in inflammation or cortisol levels [3][4][8][9]. Other strategies, like increasing dietary fiber, omega-3 fatty acids, or specific prebiotics, have also been linked to better mood outcomes in some cases [3][4]. Early studies on fecal microbiota transplantation in humans with psychiatric symptoms suggest that transferring healthy microbiota can influence inflammatory and metabolic markers - and, in some cases, improve mood [3][4].
Challenges in Proving Causation
Despite the growing body of evidence, proving a direct cause-and-effect relationship between gut health and mental health in humans is difficult. Many studies are observational, making it unclear whether gut changes lead to mood disorders or are simply a byproduct of other factors like stress, diet, or medication use [3][4]. Small sample sizes, inconsistent methods, and a lack of long-term follow-ups also limit the strength of current findings [3].
Confounding factors like medication use, comorbid conditions, and socioeconomic influences add further complexity. Additionally, depression and anxiety are not uniform conditions - they likely involve multiple subtypes with distinct biological causes. This means that gut-brain dysfunction may play a role in some cases but not others [3][4].
Animal studies, while informative, don’t always translate directly to humans. Controlled lab environments differ significantly from the complexities of human life, including genetics, diet, and social factors. Moreover, the doses and strains of probiotics tested in animals may not be practical or safe for human use [3][4].
"This clinician wants to clarify that larger-scale research to support their product claims is still developing." - Verified Clinician, Internal Medicine, Begin Rebirth RE-1™ [1]
While the gut-brain axis is an important piece of the mental health puzzle, it’s not the whole story. For now, promoting gut health - through anti-inflammatory diets, adequate fiber intake, and evidence-based probiotics - can complement traditional psychiatric treatments. However, more rigorous research is needed to identify which patients are most likely to benefit from these approaches and to refine them for clinical use.
Treatment Approaches Targeting the Gut-Brain Axis
Efforts to address issues within the gut-brain axis focus on reducing neuroinflammation, rebalancing the gut microbiome, and supporting the body’s stress response. These strategies combine anti-inflammatory therapies, microbiome-based interventions, and lifestyle modifications.
Anti-Inflammatory Therapies
Inflammation is a key factor in certain types of anxiety and depression, particularly in individuals with high inflammatory markers or coexisting conditions like obesity, cardiovascular disease, or autoimmune disorders.
Research, including meta-analyses of randomized trials, indicates that anti-inflammatory treatments - such as COX-2 inhibitors and TNF-α inhibitors - can provide modest relief from depressive symptoms, particularly for those with elevated inflammatory markers. However, these treatments come with potential long-term safety concerns and should be closely monitored by healthcare professionals [4]. Omega-3 fatty acids, especially EPA-rich formulations, have also shown promise. Studies highlight their anti-inflammatory properties and their ability to improve depressive symptoms when used alongside antidepressants [4]. Additionally, dietary patterns like the Mediterranean diet, which focus on fiber, polyphenols, and unsaturated fats, have been linked to lower inflammation and reduced depression risk, as demonstrated by studies like the SMILES trial [4].
Preclinical research has also explored experimental approaches. For example, blocking peripheral IL-6 receptors has led to rapid and sustained antidepressant effects in animal models by rebalancing gut microbiota. Similarly, new agents like NLRP3 inflammasome inhibitors have shown potential to reduce microglial activation and improve anxiety- and depression-like behaviors [3][4]. While these findings are encouraging, more research is needed to establish standardized biomarkers and long-term safety before these therapies can be widely adopted [3][4].
Microbiome-Based Interventions
Restoring gut health has emerged as a key strategy for addressing the gut-brain axis. These interventions include dietary changes, probiotics, prebiotics, and synbiotics, all aimed at improving microbial balance, strengthening the gut barrier, and promoting beneficial metabolites.
- Dietary changes: Incorporating vegetables, fruits, whole grains, legumes, nuts, and seeds into daily meals, along with fermented foods like yogurt, kefir, or sauerkraut, can boost microbial diversity. These choices encourage the production of short-chain fatty acids, reduce systemic inflammation, and lower the risk of depressive symptoms [3][4].
- Probiotics: Often referred to as psychobiotics when used for mental health, probiotics introduce beneficial bacteria that can influence brain function. Strains like Lactobacillus and Bifidobacterium have been shown in trials to reduce anxiety- and depression-like behaviors in animal models. In humans, these probiotics have demonstrated modest improvements in mood, stress levels, and HPA axis markers over 4–8 weeks [3][7].
- Prebiotics: Compounds like galacto-oligosaccharides (GOS) and fructo-oligosaccharides (FOS) nourish beneficial gut bacteria. Small studies suggest prebiotics can enhance microbial populations, modulate cytokine responses, and even reduce cortisol awakening responses, which may improve emotional processing [3].
- Synbiotics: These combine probiotics and prebiotics to maximize gut health benefits. Early research shows they can improve gut barrier function, lower inflammatory markers, and positively affect behavior. Effective synbiotic products require careful consideration of strain specificity, dosage (often billions of CFU per day), and proper storage. Improvements are typically gradual, taking 4–8 weeks [3][7].
Begin Rebirth RE‑1™: A 3-in-1 Synbiotic Solution
Begin Rebirth RE‑1™ takes microbiome-based strategies to the next level with its comprehensive 3-in-1 formulation. This product combines prebiotics, probiotics, and postbiotics in a single synbiotic blend designed to restore gut health over the short, medium, and long term. Each serving delivers an impressive 500 billion CFU through a Lyosublime™ delivery system, ensuring the survival of beneficial strains during processing and digestion.
The formula features 7 Human Origin Strains (HOSt™) that are crucial for gut health and immune support. Among them, specific strains offer mental health benefits:
- Lactobacillus helveticus BR‑MCC1848 has been shown to counteract gene expression changes brought on by chronic stress, potentially preventing stress-induced depression.
- Bifidobacterium infantis BR‑M63 has demonstrated effectiveness in improving mental health in individuals dealing with post-IBS conditions.
- Lactobacillus gasseri BR‑LAC‑343 has been linked to better sleep quality in adults experiencing mild to moderate stress [1].
The prebiotic component includes 4.5 grams of fiber, a mix of GOS and inulin, which nourishes beneficial bacteria and supports the production of short-chain fatty acids. This innovative approach highlights the growing role of microbiome-targeted solutions in mental health management.
Conclusion
Chronic stress wreaks havoc on the gut-brain axis, creating a continuous cycle that fuels anxiety, depression, and cognitive challenges. When stress hormones flood the body, they weaken the gut's protective barrier, disrupt the balance of gut microbes, and spark immune responses that eventually impact the brain. This chain reaction - stress altering the gut, gut changes driving inflammation, and inflammation affecting brain function - forms a self-perpetuating loop that complicates mental health recovery. These disruptions are at the core of experimental and clinical findings discussed in the research below. [3][4]
Research strongly supports these connections. Animal studies reveal that shifting gut microbiota can influence stress responses, anxiety-like behaviors, and brain inflammation through microglial activity. Human studies mirror these findings, showing similar inflammatory markers that tie the gut and brain together. While most human data remain observational and stop short of proving direct causation, evidence from multiple scientific fields reinforces the idea of the gut, immune system, and brain functioning as an interconnected network.
With this understanding, microbiome-targeted therapies are emerging as promising additions to traditional mental health treatments. Gut-focused strategies, including anti-inflammatory therapies, dietary modifications, and microbiome-based solutions, are showing encouraging results in early studies. For instance, clinically designed products like Begin Rebirth RE-1™ aim to restore gut balance and support immune health. With 500 billion CFU per sachet and a Lyosublime™ delivery system, it offers structured programs - spanning 7 days to 3 months - to promote microbiome health and immune regulation.
However, there are still unanswered questions. What microbial markers best predict who will respond to treatment? How long do the benefits last after therapy ends? And how can these approaches be effectively combined with standard psychiatric medications? Much of the current knowledge comes from animal studies, and translating these findings to diverse human populations - each with unique diets, environments, and health conditions - remains a challenge. Large-scale clinical trials are essential to pinpoint which patients benefit most, determine optimal dosages and treatment durations, and ensure long-term safety. [3][4]
For individuals dealing with anxiety, depression, or chronic stress, addressing gut health, inflammation, diet, and stress management as part of mental health care is becoming increasingly important. Collaborating with healthcare professionals can help individuals explore integrated approaches that combine stress-reduction techniques, anti-inflammatory lifestyle changes, conventional treatments, and carefully selected microbiome-targeted therapies. Products like Begin Rebirth RE-1™ should be viewed as supplements to a comprehensive, evidence-based treatment plan rather than standalone fixes.
The field is advancing quickly. Ongoing research, including multi-omics studies, is shedding light on the intricate relationships between the gut, immune system, and brain across different populations and conditions. As experts from neuroscience, immunology, gastroenterology, and psychiatry continue to collaborate, the potential for personalized, microbiome-informed treatments grows. The gut-brain axis is shaping up to be a key framework for understanding and addressing mental health challenges in the modern era.
FAQs
How does chronic stress affect the gut microbiome and mental health?
Chronic stress has a knack for throwing off the balance of your gut microbiome - a condition called dysbiosis. When this happens, it can spark inflammation and interfere with the gut-brain axis, the vital communication system connecting your digestive system to your brain.
This disruption doesn’t just stay in your gut. Over time, it can play a role in mental health struggles like anxiety, depression, and unpredictable mood changes. Taking care of your gut health isn’t just about digestion - it’s key to supporting your overall physical and mental well-being.
How do prebiotics and probiotics help support gut health and mental well-being?
Prebiotics and probiotics are key players in keeping your gut microbiome in good shape, which has a strong connection to mental health through the gut-brain axis. Prebiotics serve as nourishment for the beneficial bacteria in your gut, encouraging their growth. On the other hand, probiotics deliver live, healthy bacteria to help restore balance in the gut. Together, they can improve digestion, bolster the immune system, and potentially ease stress and neuroinflammation, contributing to overall wellness.
Products like Begin Rebirth RE-1™ take it a step further by combining prebiotics, probiotics, and postbiotics to reset the gut microbiome and support both your physical and mental health.
Why is it challenging to establish a direct connection between gut health and mood disorders like anxiety and depression?
Proving a clear connection between gut health and mood disorders like anxiety and depression isn't straightforward. This complexity stems from the intricate nature of the gut-brain axis and the many factors influencing mental health. Differences in microbiome composition, genetics, lifestyle habits, and external influences all intertwine, making it challenging to pinpoint a direct cause-and-effect relationship.
While studies have highlighted links between gut health and mental well-being, establishing causation demands long-term, detailed research. Adding to the challenge is the complicated relationship between stress, neuroinflammation, and the gut-brain axis, which can vary widely among individuals.